Suppression of Ribose-5-Phosphate Isomerase a Induces ROS to Activate Autophagy, Apoptosis, and Cellular Senescence in Lung Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Jul 2022
Historique:
received: 29 06 2022
revised: 14 07 2022
accepted: 15 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Ribose-5-phosphate isomerase A (RPIA) regulates tumorigenesis in liver and colorectal cancer. However, the role of RPIA in lung cancer remains obscure. Here we report that the suppression of RPIA diminishes cellular proliferation and activates autophagy, apoptosis, and cellular senescence in lung cancer cells. First, we detected that RPIA protein was increased in the human lung cancer versus adjust normal tissue via tissue array. Next, the knockdown of RPIA in lung cancer cells displayed autophagic vacuoles, enhanced acridine orange staining, GFP-LC3 punctae, accumulated autophagosomes, and showed elevated levels of LC3-II and reduced levels of p62, together suggesting that the suppression of RPIA stimulates autophagy in lung cancer cells. In addition, decreased RPIA expression induced apoptosis by increasing levels of Bax, cleaved PARP and caspase-3 and apoptotic cells. Moreover, RPIA knockdown triggered cellular senescence and increased p53 and p21 levels in lung cancer cells. Importantly, RPIA knockdown elevated reactive oxygen species (ROS) levels. Treatment of ROS scavenger N-acetyl-L-cysteine (NAC) reverts the activation of autophagy, apoptosis and cellular senescence by RPIA knockdown in lung cancer cells. In conclusion, RPIA knockdown induces ROS levels to activate autophagy, apoptosis, and cellular senescence in lung cancer cells. Our study sheds new light on RPIA suppression in lung cancer therapy.

Identifiants

pubmed: 35887232
pii: ijms23147883
doi: 10.3390/ijms23147883
pmc: PMC9322731
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
Aldose-Ketose Isomerases EC 5.3.1.-
ribosephosphate isomerase EC 5.3.1.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Tsing Hua University, Taiwan
ID : 107Q2514E1, 109Q2506E1, 111F7MDSE1
Organisme : Ministry of Science and Technology, Taiwan
ID : 106-2311-B007-006-MY2, 108-2320-B-400 -005 -MY3, 109-2311-B-007-002, 110-2320-B-007-003
Organisme : National Health Research Institutes
ID : MG-109-PP-06

Références

Perspect Medicin Chem. 2008 Jan 18;1:64-82
pubmed: 19812737
Biosci Rep. 2015 Apr 22;35(3):
pubmed: 26182361
J Appl Clin Med Phys. 2014 May 08;15(3):4748
pubmed: 24892352
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
pubmed: 17717517
Am J Cancer Res. 2012;2(4):397-413
pubmed: 22860231
Mol Cancer Ther. 2011 Sep;10(9):1533-41
pubmed: 21878654
Int J Mol Sci. 2021 Nov 17;22(22):
pubmed: 34830283
Cell. 2012 Apr 27;149(3):656-70
pubmed: 22541435
Cell Signal. 2016 Sep;28(9):1380-8
pubmed: 27328773
Int J Biochem Cell Biol. 2009 Jul;41(7):1482-94
pubmed: 19401148
Oncogene. 1999 Dec 13;18(53):7676-80
pubmed: 10618707
Cell Prolif. 2012 Dec;45(6):487-98
pubmed: 23030059
Oncogene. 2006 Aug 28;25(38):5257-62
pubmed: 16936745
World J Biol Chem. 2013 Aug 26;4(3):64-70
pubmed: 23977422
J Cell Biol. 2011 Feb 21;192(4):547-56
pubmed: 21321098
Sci Rep. 2018 Sep 3;8(1):13134
pubmed: 30177747
Ann Hum Genet. 1980 May;43(4):335-42
pubmed: 7396409
Curr Med Chem. 2009;16(10):1229-35
pubmed: 19355881
Methods Enzymol. 2009;452:181-97
pubmed: 19200883
Int J Cancer. 2013 Jun 1;132(11):2682-93
pubmed: 23151917
Nature. 2007 Aug 16;448(7155):767-74
pubmed: 17700693
J Clin Invest. 2003 Dec;112(12):1809-20
pubmed: 14638851
Cancer Cell. 2010 Aug 9;18(2):135-46
pubmed: 20708155
Front Biosci. 2008 Jan 01;13:3116-26
pubmed: 17981781
J Cell Biol. 2011 Jul 11;194(1):7-15
pubmed: 21746850
PLoS One. 2011;6(9):e25323
pubmed: 21980427
Cancer Cell. 2012 Mar 20;21(3):297-308
pubmed: 22439925
Trends Mol Med. 2006 Sep;12(9):440-50
pubmed: 16899408
Int J Cancer. 2009 Mar 15;124(6):1330-7
pubmed: 19065656
Eur J Cancer. 2012 Jun;48(9):1299-311
pubmed: 22464348
Cancer Lett. 2015 Jan 28;356(2 Pt A):204-10
pubmed: 24486217
Trends Cell Biol. 2007 Jun;17(6):286-91
pubmed: 17481900
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4952-7
pubmed: 16547133
Bioessays. 2006 Nov;28(11):1091-101
pubmed: 17041898
Cancer Metab. 2014 Jan 23;2(1):2
pubmed: 24451478
Oncogene. 2007 May 14;26(22):3291-310
pubmed: 17496923
Carcinogenesis. 2019 May 14;40(3):461-473
pubmed: 30418535
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Arch Pathol Lab Med. 2012 Dec;136(12):1478-81
pubmed: 23194039
Aging Cell. 2012 Feb;11(1):93-103
pubmed: 22040003
N Engl J Med. 2009 Oct 8;361(15):1475-85
pubmed: 19812404
Sci Signal. 2010 Nov 09;3(147):ra81
pubmed: 21062993
Mol Cell Biochem. 2011 Feb;348(1-2):61-8
pubmed: 21069434
Nat Cell Biol. 2013 Aug;15(8):991-1000
pubmed: 23811687
Oncogene. 2005 Jun 16;24(26):4165-73
pubmed: 15806154
Trends Mol Med. 2011 Jul;17(7):395-403
pubmed: 21376665
Cancer Res. 2008 Oct 1;68(19):8022-30
pubmed: 18829560
Int J Cancer. 2015 Jul 1;137(1):104-15
pubmed: 25429733
Annu Rev Physiol. 2013;75:685-705
pubmed: 23140366
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35
pubmed: 21157483
Cell. 2009 Jun 12;137(6):1062-75
pubmed: 19524509
Nature. 1999 Dec 9;402(6762):672-6
pubmed: 10604474
Nat Commun. 2013;4:2300
pubmed: 23939249
Cell Death Dis. 2013 Oct 10;4:e838
pubmed: 24113172
Methods Mol Biol. 2010;648:193-214
pubmed: 20700714
Oncogene. 2008 Oct 20;27(48):6245-51
pubmed: 18931691
Cell Death Differ. 2012 Dec;19(12):2015-28
pubmed: 22814619
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6505-8
pubmed: 18986809
J Inherit Metab Dis. 2008 Dec;31(6):703-17
pubmed: 18987987
Int J Cancer. 2018 Nov 1;143(9):2116-2125
pubmed: 29574749
PLoS Biol. 2018 Jan 16;16(1):e2003714
pubmed: 29337987
Gastroenterology. 2015 Nov;149(6):1587-1598.e11
pubmed: 26248089
Nat Rev Cancer. 2009 Jun;9(6):400-14
pubmed: 19440234
Nat Commun. 2022 Mar 18;13(1):1417
pubmed: 35304872

Auteurs

Yu-Chin Nieh (YC)

Institute of Biotechnology, National Tsing Hua University, Hsinchu 300044, Taiwan.

Yu-Ting Chou (YT)

Institute of Biotechnology, National Tsing Hua University, Hsinchu 300044, Taiwan.

Yu-Ting Chou (YT)

Division of Hematology and Oncology, Department of Medicine, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA 94158, USA.

Chao-Yung Wang (CY)

Department of Cardiology, Chang Gung Memory Hospital, Linkou Main Branch, Chang Gung University, Taoyuan 33305, Taiwan.

Shi-Xian Lin (SX)

Institute of Biotechnology, National Tsing Hua University, Hsinchu 300044, Taiwan.

Shih-Ci Ciou (SC)

Institute of Biotechnology, National Tsing Hua University, Hsinchu 300044, Taiwan.

Chiou-Hwa Yuh (CH)

Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan 35053, Taiwan.
Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu 300044, Taiwan.
Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu 300093, Taiwan.
Ph.D. Program in Environmental and Occupational Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.

Horng-Dar Wang (HD)

Institute of Biotechnology, National Tsing Hua University, Hsinchu 300044, Taiwan.
Institute of Systems Neuroscience, National Tsing Hua University, Hsinchu 300044, Taiwan.
Department of Life Science, National Tsing Hua University, Hsinchu 300044, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH